Noticias de SNY_US

Noticias del mercado

Últimas noticias sobre SNY_US — 519 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNY_US ✕ 519 resultados
18/04/2026 SNY_US — MarketScreener ES ← EN
La vacuna Nuvaxovid Covid-19 de Sanofi mostró una mejor tolerabilidad que Mnexspike en un estudio comparativo
18/04/2026 SNY_US — Yahoo Finance ES ← EN
Comunicado de prensa: ESCMID: La vacuna Nuvaxovid COVID-19 de Sanofi mostró una mejor tolerabilidad que mNEXSPIKE en un estudio comparativo
18/04/2026 SNY_US — Yahoo Finance
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
17/04/2026 SNY_US — Sanofi
It’s Time to Look Beyond the Bleed
17/04/2026 SNY_US — PETA
Sanofi Urged to Probe Studies Using Monkeys From Filthy Lab After PETA Exposé
16/04/2026 SNY_US — Medical Marketing and Media
The Escalator: Sanofi, Merck, Novo Nordisk and more
16/04/2026 SNY_US — Yahoo Finance
Sanofi Expands Immunology Footprint With New Approvals And Respiratory Data
15/04/2026 SNY_US — Oncology Pipeline
Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis
14/04/2026 SNY_US — GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares - March 2026
13/04/2026 SNY_US — Fox Business
Merck, Sanofi are latest companies to add medications to TrumpRx
12/04/2026 SNY_US — Yahoo Finance
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
08/04/2026 SNY_US — Yahoo Finance
Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents
07/04/2026 SNY_US — Yahoo Finance
How The Sanofi (ENXTPA:SAN) Story Is Shifting As Fair Value And Assumptions Are Reworked
07/04/2026 SNY_US — GlobeNewswire
Press Release: Sanofi’s lunsekimig met primary and key
07/04/2026 SNY_US — Clinical Trials Arena
Sanofi’s bispecific scores in respiratory diseases but fails in eczema
07/04/2026 SNY_US — Fierce Biotech
Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study
07/04/2026 SNY_US — BioSpace
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
07/04/2026 SNY_US — BioPharma Dive
Sanofi immune drug hopeful posts mixed results in mid-stage tests
07/04/2026 SNY_US — Yahoo Finance
Is It Time To Reconsider Sanofi (ENXTPA:SAN) After Recent Share Price Weakness?
07/04/2026 SNY_US — FirstWord Pharma
Sanofi's lunsekimig scores dual mid-stage wins in respiratory trials, stumbles in dermatitis

Página 25 de 26

keyboard_arrow_up